Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
38.97
-0.52 (-1.32%)
Sep 3, 2026, 2:53 PM EDT - Market open
Immunovant Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst UBS No rating | UBS | Hold Reiterates $24 → $40 | Hold | Reiterates | $24 → $40 | +2.64% | Aug 24, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $49 → $57 | Buy | Maintains | $49 → $57 | +46.27% | Aug 11, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $50 | Buy | Maintains | $50 | +28.30% | Aug 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $40 → $41 | Buy | Reiterates | $40 → $41 | +5.21% | Aug 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $54 | Buy | Reiterates | $54 | +38.57% | Aug 7, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $53 | Buy | Maintains | $53 | +36.00% | Aug 7, 2026 |
| Truist Financial | Truist Financial | Hold Maintains $30 | Hold | Maintains | $30 | -23.02% | Aug 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $66 | Buy | Maintains | $66 | +69.36% | Aug 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.